6-Acetoxy-7-methoxy-3H-quinazolin-4-one

GTC-181

Pharmaceutical Intermediates

6-Acetoxy-7-methoxy-3H-quinazolin-4-one

CAS No.
179688-53-0
Catalogue ID
GTC-181

6-Acetoxy-7-methoxy-3H-quinazolin-4-one, CAS 179688-53-0. Source-derived identification, physical data and applications are provided for catalogue reference; request the current specification, COA and SDS for the required grade.

Catalogue aliases / related identifiers

6-Acetoxy-7-methoxy-4(3H)-quinazolinone; 3,4-Dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate; (7-Methoxy-4-oxo-1H-quinazolin-6-yl) acetate; 6-Acetoxy-7-methoxy-3,4-dihydroquinazolin-4-one; 6-Acetoxy-7-methoxy-4-hydroxyquinazoline; 6-Acetoxy-7-methoxy-4-quinazolinol; 7-Methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate

Supplied catalogue source: GTC-181 · Page 98

Reference data — confirm before ordering or use

The information below is a structured migration from the supplied catalogue snapshot. It is not a current product specification, COA or SDS. Confirm the actual supplier, grade, batch documents, classification, packing and destination requirements for your enquiry.

6-Acetoxy-7-methoxy-3,4-dihydroquinazolin-4(3H)-one is a substituted quinazolinone derivative commonly utilized as a protected intermediate in heterocyclic synthesis. Its acetoxy group at the 6-position allows for selective functionalization in multi-step processes.


Basic Information

CAS No.179688-53-0
EC No.808-050-2
Linear FormulaC11H10N2O4
Molecular Weight234.21
AppearanceVery pale yellow to pale yellow crystal - powder
Melting Point297 °C (lit.)
Boiling point390.5±52.0 °C (Predicted)
Density1.39 g/cm³ (Predicted)
SolubilitySlightly soluble in hot DMF; limited in common solvents (typical reference)
Storage ConditionsStore in a cool, dark place, sealed, recommended <15°C
Chemical StructureMolecular Structure of 6-Acetoxy-7-methoxy-3,4-dihydroquinazolin-4(3H)-one

Key Applications

  • Gefitinib intermediate: Serves as a critical building block in the multi-step synthesis of gefitinib, an EGFR tyrosine kinase inhibitor used in oncology, and fits naturally within Gefitinib, Sunitinib and Sorafenib intermediates for targeted therapy development.

  • Pharmaceutical synthesis: Employed in the preparation of quinazoline-based active pharmaceutical ingredients and related therapeutic compounds, especially among oncology drug intermediates used in anticancer API synthesis.

  • Heterocyclic construction: Provides a protected quinazolinone scaffold for further elaboration in aromatic and nitrogen-containing molecule assembly, making it relevant to quinazolinone, benzimidazole and fused heterocycle intermediates.

  • Process development: Utilized in laboratory route scouting, optimization, and scale-up studies for fine chemicals and pharmaceutical intermediates for API synthesis.

  • Custom synthesis: Applied in bespoke projects requiring high-purity acetoxy-substituted quinazolinones for research and advanced pharmaceutical development.


  • Product quality consistency: Batch-to-batch uniformity maintained through rigorous in-house quality controls suitable for pharmaceutical intermediate applications.

  • Global supply stability: Dependable export capabilities with established channels ensuring timely delivery across scales from lab to pilot quantities.

  • Documentation support: Comprehensive SDS, COA, and related certificates readily provided to facilitate sourcing, compliance, and quality verification.

  • Technical and packaging service: Expert assistance available for technical inquiries, along with flexible options such as 1kg/5kg/25kg fiber drums with PE liners or customized packaging.

Before you order

Confirm the current commercial product record.

Include the required grade or purity, quantity, preferred packing, destination country/port and required document set.

  • 01Current specification
  • 02Batch or sample COA
  • 03Product- and supplier-specific SDS
  • 04Packing and shipping review
Request product review

INQUIRY

INQUIRY